Neurology
-
Randomized Controlled Trial Multicenter Study
Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial.
To study the efficacy and safety of low-dose oral tetrahydrocannabinol (THC) in the treatment of dementia-related neuropsychiatric symptoms (NPS). ⋯ This study provides Class I evidence that for patients with dementia-related NPS, low-dose THC does not significantly reduce NPS at 21 days, though it is well-tolerated.